This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrowReprints and Permissions
Right arrow Copyright Information
Right arrow Books from ASM Press
Right arrow MicrobeWorld
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Adone, R.
Right arrow Articles by Pasquali, P.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Adone, R.
Right arrow Articles by Pasquali, P.

 Previous Article  |  Next Article 

Infection and Immunity, July 2005, p. 4198-4204, Vol. 73, No. 7
0019-9567/05/$08.00+0     doi:10.1128/IAI.73.7.4198-4204.2005
Copyright © 2005, American Society for Microbiology. All Rights Reserved.

Protective Properties of Rifampin-Resistant Rough Mutants of Brucella melitensis

R. Adone,* F. Ciuchini, C. Marianelli, M. Tarantino, C. Pistoia, G. Marcon, P. Petrucci, M. Francia, G. Riccardi, and P. Pasquali

Istituto Superiore di Sanità, Dipartimento di Sanità Alimentare ed Animale, Viale Regina Elena 299, 00161 Rome, Italy

Received 11 January 2005/ Returned for modification 2 March 2005/ Accepted 8 March 2005

Vaccination against Brucella infections in animals is usually performed by administration of live attenuated smooth B. abortus strain S19 and B. melitensis strain Rev1. They are proven effective vaccines against B. abortus in cattle and against B. melitensis and B. ovis in sheep and goats, respectively. However, both vaccines have the main drawback of inducing O-polysaccharide-specific antibodies that interfere with serologic diagnosis of disease. In addition, they retain residual virulence, being a cause of abortion in pregnant animals and infection in humans. To overcome these problems, one approach is to develop defined rough mutant Brucella strains lacking O antigen of lipopolysaccharide. B. abortus rough strain RB51, a rifampin-resistant mutant of virulent strain B. abortus 2308, is used as a vaccine against B. abortus infection in cattle in some countries. However, RB51 is not effective in sheep, and there is only preliminary evidence that it is effective in goats. In this study, we tested the efficacies of six rifampin-resistant rough strains of B. melitensis in protecting BALB/c mice exposed to B. melitensis infection. The protective properties, as well as both humoral and cellular immune responses, were assessed in comparison with those provided by B. melitensis Rev1 and B. abortus RB51 vaccines. The results indicated that these rough mutants were able to induce a very good level of protection against B. melitensis infection, similar to that provided by Rev1 and superior to that of RB51, without inducing antibodies to O antigen. In addition, all B. melitensis mutants were able to stimulate good production of gamma interferon. The characteristics of these strains encourage further evaluation of them as alternative vaccines to Rev1 in primary host species.


* Corresponding author. Mailing address: Istituto Superiore di Sanità, Dipartimento di Sanità Alimentare ed Animale, Viale Regina Elena 299, 00161 Rome, Italy. Phone: 39 06 49902728. Fax: 39 06 49387077. E-mail: adone{at}iss.it.

Editor: J. D. Clements


Infection and Immunity, July 2005, p. 4198-4204, Vol. 73, No. 7
0019-9567/05/$08.00+0     doi:10.1128/IAI.73.7.4198-4204.2005
Copyright © 2005, American Society for Microbiology. All Rights Reserved.




This article has been cited by other articles:

  • Kahl-McDonagh, M. M., Ficht, T. A. (2006). Evaluation of Protection Afforded by Brucella abortus and Brucella melitensis Unmarked Deletion Mutants Exhibiting Different Rates of Clearance in BALB/c Mice. Infect. Immun. 74: 4048-4057 [Abstract] [Full Text]